Impact of rotational atherectomy on heavily calcified, unprotected left main disease

Hiroto Yabushita1, Kensuke Takagi, Satoko Tahara

  • 1Department of Cardiology, Interventional Cardiology Unit, New Tokyo Hospital.

Insights

Percutaneous coronary intervention using rotational atherectomy for calcified unprotected left main lesions shows high procedural success. However, hemodialysis patients experienced a significantly higher rate of target lesion revascularization in the main branch.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Surgery

Background:

  • Limited data exists on percutaneous coronary intervention (PCI) with rotational atherectomy (Rota) for severely calcified unprotected left main (ULM) lesions.
  • Calcified ULM lesions pose significant challenges for revascularization procedures.

Purpose of the Study:

  • To evaluate the efficacy and safety of PCI using Rota for severely calcified ULM lesions.
  • To assess outcomes in patients with and without hemodialysis (HD).

Main Methods:

  • Retrospective evaluation of 64 consecutive patients undergoing drug-eluting stent implantation with Rota for calcified ULM lesions (Jan 2005 - Aug 2011).
  • Analysis of procedural success, periprocedural complications, and 1-year follow-up outcomes including cardiac death and target lesion revascularization (TLR).
  • Subgroup analysis comparing patients with and without hemodialysis, utilizing intravascular ultrasound (IVUS) data where available.

Main Results:

  • High procedural success rate (95.3%) was achieved with low rates of fatal complications and periprocedural myocardial infarction (7.8%).
  • At 1-year follow-up, cardiac death was 6.3%, and overall TLR was 18.8%.
  • Hemodialysis patients showed a significantly higher rate of target lesion revascularization in the main branch (TLR-MB) compared to non-HD patients (46.2% vs. 2.1%, P=0.003), despite optimal stent expansion in some HD patients.

Conclusions:

  • PCI with Rota for calcified ULM lesions offers high procedural success and low immediate complications.
  • While outcomes are acceptable for non-HD patients, HD patients face a considerably higher risk of TLR-MB, even with optimal stent expansion.
Abstract

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
726
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
653
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
443